Emma Beausang
Consejero General en GH RESEARCH PLC .
Cargos activos de Emma Beausang
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GH RESEARCH PLC | Consejero General | - | - |
Historial de carrera de Emma Beausang
Antiguos cargos conocidos de Emma Beausang.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Consejero General | - | 01/12/2021 |
Formación de Emma Beausang.
| University of Strathclyde | Undergraduate Degree |
| UCL School of Pharmacy | Doctorate Degree |
Estadísticas
Internacional
| Reino Unido | 3 |
| Estados Unidos | 2 |
| Irlanda | 2 |
Operativa
| General Counsel | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Emma Beausang
- Experiencia
